In its latest publication on the peripheral vascular devices market, Meticulous Research® analyses that the market is expected to grow at a CAGR of 6.9% from 2021 to 2028 to reach $12.02 billion. The increasing prevalence of peripheral vascular diseases associated with obesity, diabetes, and hypertension; growing geriatric population; increasing demand for minimally invasive treatment options; and increasing prevalence of disease-causing lifestyles are the major factors driving the growth of this market.
To provide efficient analysis, Meticulous Research has segmented this market based on type [angioplasty balloons (old/normal balloons, drug-eluting balloons, cutting & scoring balloons); angioplasty stents (drug-eluting stents, bare-metal stents (expandable balloon stents, self-expandable stents)); catheters (angiography catheters, guiding catheters, IVUS/OCT catheters); endovascular aneurysm repair stent grafts (abdominal aortic aneurysm stent-grafts, thoracic aortic aneurysm stent grafts); inferior vena cava filters (retrievable filters, permanent filters); plaque modification devices (atherectomy devices, thrombectomy devices); hemodynamic flow alteration devices (embolic protection devices, chronic total occlusion devices); and other devices] and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
Download Free Sample Report Copy Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5180
Scope of the Report:
Peripheral Vascular Devices Market, by Type
- Angioplasty Balloons
- Old/Normal Balloons
- Drug-eluting Balloons
- Angioplasty Stents
- Drug-eluting Stents
- Bare Metal Stents
- Balloon-expandable Stents
- Self-expandable Stents
- Angiography Catheters
- Guiding Catheters
- IVUS/OCT Catheters
- Endovascular Aneurysm Repair Stent Grafts
- Abdominal Endovascular Aneurysm Stent Grafts
- Thoracic Endovascular Aneurysm Stent Grafts
- Inferior Vena Cava Filters
- Retrievable Filters
- Permanent Filters
- Plaque Modification Devices
- Atherectomy Devices
- Thrombectomy Devices
- Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
- Other Devices
Peripheral Vascular Devices Market, by Geography
- North America
- Rest of Europe (RoE)
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5180
Based on type, the peripheral vascular devices market is segmented into angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other types. In 2020, the angioplasty stents segment accounted for the largest share of the peripheral vascular devices market. Factors driving the growth of this segment include reduced restenosis rate associated with these products and their benefits, such as smaller incisions, faster recovery time, and lower risk of complications.
Based on geography, this research report analyzes and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2020, North America dominated the peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; increasing number of obese & diabetic population; and the presence of key players are driving the growth of this regional segment.
To gain more insights into the market with a detailed table of content and figures, click here : https://www.meticulousresearch.com/product/peripheral-vascular-devices-market-5180
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, market share analysis, and geographical presence on some of the key players in this market, including Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), BIOTRONIK SE & Co. KG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Edwards Lifesciences Corporation (U.S.), iVascular (Spain), Koninklijke Philips N.V. (Netherlands), Medtronic Public Limited Company (Ireland), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), and Terumo Corporation (Japan).
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Company Name: Meticulous Market Research Pvt Ltd
Contact Person: Khushal Bombe
Email: Send Email
Phone: +1 646-781-8004
Address:1267 Willis St, Ste 200 Redding, California, 96001, U.S.
Country: United States